Fun and excitement guaranteed: Rowing against cancer charity regatta on September 7 in Heidelberg

For the 13th time, exciting races and good entertainment will be on offer on September 7 on the Neckar and along its banks in Heidelberg: The first heats of the charity regatta Rowing against Cancer - jointly organized by the Foundation Living with Cancer, the Rowing Society Heidelberg 1898 e.V. (RGH) and the National Center for Tumor Diseases (NCT) Heidelberg - will start at 9 am. Parallel to the rowing competitions, there will be a varied program for visitors in the regatta village and on the stage. The proceeds will benefit the Exercise and Cancer Patient Program at the NCT Heidelberg.

The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD), Thoraxklinik-Heidelberg and the Medical Faculty of Heidelberg University.

Rowing together for a good cause - that is the aim and the great fun of Rowing against Cancer. The charity regatta organized by the Foundation Leben mit Krebs, the Rudergesellschaft Heidelberg 1898 e.V. (RGH) and the National Center for Tumor Diseases (NCT) Heidelberg is being held for the 13th time this year. As always, beginners and experienced water sports enthusiasts, patients, relatives and medical and nursing staff will be rowing on the Neckar.

In sporting terms, everything revolves around the races in the gig double fours. The boats start below the Theodor Heuss Bridge and then travel 300 meters downstream to the finish line. The winning boats in all heats qualify directly for the finals in the afternoon, and there are also hope heats that offer amateur rowers a second chance. In order to keep as straight a course as possible, experienced RGH members take on the role of helmsmen on the boats.

An attractive supporting program for the whole family accompanies the races in the regatta village and on the stage on the Neckarwiese in Neuenheim. This includes a wide range of culinary delights and many information stands as well as hands-on activities - from the presentation of the Patient Advisory Board at the NCT Heidelberg and many self-help groups for cancer patients to the rowing ergometer and face painting for children. Patrons of the event are Manfred Lautenschläger, founder and Honorary Chairman of the Supervisory Board of MLP SE, and Heidelberg's Lord Mayor Eckart Würzner.

Back from the Olympic Games and also present in the Regatta Village is Team Paris from the Metropolregion Rhein-Neckar. From 2 p.m., long jumper Mikaelle Assani, canoeist Saeid Fazloula, pole vaulter Oleg Zernikel and field hockey player Sonja Zimmermann will talk about their experiences at the Olympics. Afterwards, they and other athletes will be available to sign autographs.

The aim of the charity event is to make exercise visible as a contribution to the fight against cancer. Entry fees, sponsorship money and donations will be used to provide sports and exercise programs for cancer patients. Thomas Bellut, Chairman of the Board of the Living with Cancer Foundation, says: "Rowing against cancer provides an impetus for anchoring sports programs in oncological treatment. If possible, all patients should take part in a program and actively improve their therapy."

Dirk Jäger, Managing Director at the NCT Heidelberg and Head of Medical Oncology at the UKHD, says: "The proceeds from the regatta will be used to further expand the Exercise and Cancer program at the NCT Heidelberg. This will enable us to offer our patients extensive sports and exercise therapy activities that have been proven to help reduce or even prevent complications and side effects during or after cancer treatment."

Facts and figures

Rowing against cancer: 13th charity regatta on the Neckar in Heidelberg

Date: Saturday, September 7, 2024,

from 8 am start number distribution

Race from 9 am

Organizer: Foundation Leben mit Krebs

Coordinator: National Center for Tumor Diseases (NCT) Heidelberg

Organizer: Rudergesellschaft Heidelberg 1898 e.V. (RGH)

Contact: Sönke Hartung-Rey, Tel.: 06221-3219246, s.hartung-rey@rgh-heidelberg.de

Venue: Neckar and Neckarwiese, Neuenheim, Heidelberg

Race course: 300 meters

Boat class: Gig double four with helmsmen

Participants/teams: Various classes for women, men and mixed, patients, participants with rowing experience

Competition format: preliminary and hopeful heats, final

Participants in the accompanying program and in the regatta village

Patient advisory board and pilot service of the NCT Heidelberg

Cancer self-help groups

Head and neck tumors (KHT)
Neuroendocrine tumors (Net)
Prostate Rhine-Neckar
Li-Fraumeni Syndrome Association Germany
Mammazone - Women and Research against Breast Cancer e.V.
BRCA Network

Information stands

Network OnkoAktiv
Foundation Leben mit Krebs
Krebsinformationsdienst (Cancer Information Service of the German Cancer Research Center)
NAOK - Network ActiveOncoKids
MSD
Yoga and cancer
TSG Hoffenheim
Zentrum aktiver Prävention/ ZAP
Therapiezentrum Heidelberg
Akademie der Gesundheitsberufe

Special offers

Yoga to join in, 11:15 to 12:00 and 13:45 to14:30
Face painting for children
Rowing ergometer
Massage
Soccer parkour

Music and dance on stage

A picture of the press release is available free of charge at

https://www.nct-heidelberg.de/fileadmin/media/nct-heidelberg/news/pressemitteilungen/Rudern_gegen_Krebs_23_nct-heidelberg.JPG

Note on the use of image material for press releases

Use is free of charge. The NCT Heidelberg permits one-time use in connection with reporting on the topic of the press release. Please indicate the copyright "NCT Heidelberg" as picture credits. The image material may only be passed on to third parties after prior consultation with NCT Communications (phone: +49 6221 42-1755, e-mail: martin.staiger@nct-heidelberg.de). Use for commercial purposes is prohibited.

Contact for the press:

Dr. Martin Staiger
Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
Kommunikation und Veranstaltungen
Im Neuenheimer Feld 460
69120 Heidelberg
Tel.: +49 6221 42-1755
E-Mail: martin.staiger@nct-heidelberg.de
www.nct-heidelberg.de

Dr. Sibylle Kohlstädt
Deutsches Krebsforschungszentrum (DKFZ)
Strategische Kommunikation und Öffentlichkeitsarbeit
Im Neuenheimer Feld 280
69120 Heidelberg
Tel.: +49 6221 42-2843
Fax: +49 6221 42-2968
E-Mail: s.kohlstaedt@dkfz.de
www.dkfz.de

Dr. Stefanie Seltmann
Universitätsklinikum Heidelberg und Medizinische Fakultät der Universität Heidelberg
Presse- und Öffentlichkeitsarbeit
Im Neuenheimer Feld 672
69120 Heidelberg
Tel.: +49 6221 56-5052
Fax: +49 6221 56-4544
E-Mail: stefanie.seltmann(at)med.uni-heidelberg.de
www.klinikum.uni-heidelberg.de

National Center for Tumor Diseases (NCT) Heidelberg

The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD), the Thoraxklinik-Heidelberg and the Medical Faculty of Heidelberg University. The aim of the NCT Heidelberg is to transfer promising approaches from cancer research to the clinic as quickly as possible and thus benefit patients. This applies to diagnosis as well as treatment, aftercare and prevention. Participation in clinical trials opens up access to innovative therapies. The NCT Heidelberg is therefore leading the way in transferring new research results from the laboratory to the clinic. The NCT Heidelberg, founded in 2004, is part of the NCT with further sites in Berlin, Dresden, SouthWest (Tübingen-Stuttgart/Ulm), WERA (Würzburg, Erlangen, Regensburg, Augsburg) and West (Essen/Cologne).

German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

National Center for Tumor Diseases (NCT, 6 sites)
German Cancer Consortium (DKTK, 8 sites)
Hopp Children's Cancer Center (KiTZ) Heidelberg
Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
National Cancer Prevention Center (jointly with German Cancer Aid)

The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

Heidelberg University Hospital and Faculty of Medicine: Internationally Renowned Patient Care, Research and Teaching

Heidelberg University Hospital (Universitätsklinikum Heidelberg, UKHD) is one of the largest and most prestigious medical centers in Germany. The Medical Faculty of Heidelberg University (Medizinische Fakultät Heidelberg, MFHD) belongs to the internationally renowned biomedical research institutions in Europe. Both institutions have the common goal of developing new therapies and implementing them rapidly for patients. Heidelberg University Hospital and the Medical Faculty of Heidelberg University employs around 14.500 employees and is committed to providing trainings and qualifications. Every year, around 86,000 patients and more than 1.100.000 outpatient cases are treated in more than 50 clinical departments with almost 2.500 beds.

Together with the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the German Cancer Aid, the UKHD established the first National Center for Tumor Diseases (NCT) in Heidelberg. The goal is to provide care at the highest level as an oncology center of excellence and to rapidly transfer promising approaches from cancer research to the hospital. In addition, the UKHD operates in partnership with the DKFZ and the University of Heidelberg the Hopp Children’s Cancer center Heidelberg (KiTZ), a unique and nationally known therapy and research center for oncological and hematological diseases in children and adolescents.

The Heidelberg Curriculum Medicinale (HeiCuMed) is one of the top medical training programs in Germany. Currently, there are about 4.000 future physicians studying in Heidelberg.